Association of cognitive function with serum uric acid level among Chinese nonagenarians and centenarians

Experimental Gerontology

Volumn 45, Issue 5, 2010, Pages 331-335

  Li, Jun ^a   Dong, Bi Rong ^a   Lin, Pin ^a   Zhang, Jie ^a   Liu, Guan Jian ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cognitive impairment; Cross sectional study; Elderly; MMSE; Serum uric acid

Indexed keywords

URIC ACID;

AGED; AGING; ARTICLE; CHINESE; COGNITIVE DEFECT; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MINI MENTAL STATE EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; URIC ACID BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; URIC ACID;

EID: 77951090682     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2010.01.005     Document Type: Article

References (38)

1. Akdemir H., Asik Z., et al. The effect of allopurinol on focal cerebral ischaemia: an experimental study in rabbits. Neurosurg. Rev. 2001, 24(2-3):131-135.
2. Ames B.N., Cathcart R., et al. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. USA 1981, 78(11):6858-6862.
3. Becker B.F. Towards the physiological function of uric acid. Free Radic. Biol. Med. 1993, 14(6):615-631.
4. Cutler R.G. Urate and ascorbate: their possible roles as antioxidants in determining longevity of mammalian species. Arch. Gerontol. Geriatr. 1984, 3(4):321-348.
5. de Lau L.M., Koudstaal P.J., et al. Serum uric acid levels and the risk of Parkinson disease. Ann. Neurol. 2005, 58(5):797-800.
6. Degrell I., Niklasson F. Purine metabolites in the CSF in presenile and senile dementia of Alzheimer type, and in multi infarct dementia. Arch. Gerontol. Geriatr. 1988, 7(2):173-178.
7. DiIorio A., Cherubini A., et al. Markers of inflammation, vitamin E and peripheral nervous system function: the InCHIANTI study. Neurobiol. Aging 2006, 27(9):1280-1288.
8. Domagk G.F., Schlicke H.H. A colorimetric method using uricase and peroxidase for the determination of uric acid. Anal. Biochem. 1968, 22(2):219-224.
9. Euser S.M., Hofman A., et al. Serum uric acid and cognitive function and dementia. Brain 2009, 132(Pt 2):377-382.
10. Evans D.A. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q. 1990, 68(2):267-289.
11. Feig D.I., Johnson R.J. Hyperuricemia in childhood primary hypertension. Hypertension 2003, 42(3):247-252.
12. Fernandes M.A., Proenca M.T., et al. Influence of apolipoprotein E genotype on blood redox status of Alzheimer's disease patients. Int. J. Mol. Med. 1999, 4(2):179-186.
13. Gackowski D., Rozalski R., et al. Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia. J. Neurol. Sci. 2008, 266(1-2):57-62.
14. Hayden M.R., Tyagi S.C. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr. Metab. (Lond.) 2004, 1(1):10.
15. Irizarry M.C., Raman R., et al. Plasma urate and progression of mild cognitive impairment. Neurodegener. Dis. 2009, 6(1-2):23-28.
16. Kim T.S., Pae C.U., et al. Decreased plasma antioxidants in patients with Alzheimer's disease. Int. J. Geriatr. Psychiatry 2006, 21(4):344-348.
17. Launer L.J. Diabetes and brain aging: epidemiologic evidence. Curr. Diab. Rep. 2005, 5(1):59-63.
18. Loenen H.M., Eshuis H., et al. Serum uric acid correlates in elderly men and women with special reference to body composition and dietary intake (Dutch Nutrition Surveillance System). J. Clin. Epidemiol. 1990, 43(12):1297-1303.
19. Maesaka J.K., Wolf-Klein G., et al. Hypouricemia, abnormal renal tubular urate transport, and plasma natriuretic factor(s) in patients with Alzheimer's disease. J. Am. Geriatr. Soc. 1993, 41(5):501-506.
20. Markesbery W.R., Lovell M.A. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch. Neurol. 2007, 64(7):954-956.
21. Maxwell S.R., Thomason H., et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 1997, 27(6):484-490.
22. Newman A.B., Fitzpatrick A.L., et al. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J. Am. Geriatr. Soc. 2005, 53(7):1101-1107.
23. Nieto F.J., Iribarren C., et al. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?. Atherosclerosis 2000, 148(1):131-139.
24. Nunomura A., Castellani R.J., et al. Involvement of oxidative stress in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2006, 65(7):631-641.
25. Patterson R.A., Horsley E.T., et al. Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid. J. Lipid Res. 2003, 44(3):512-521.
26. Plassman B.L., Langa K.M., et al. Prevalence of cognitive impairment without dementia in the United States. Ann. Intern. Med. 2008, 148(6):427-434.
27. Rinaldi P., Polidori M.C., et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol. Aging 2003, 24(7):915-919.
28. Schretlen D.J., Inscore A.B., et al. Serum uric acid and cognitive function in community-dwelling older adults. Neuropsychology 2007, 21(1):136-140.
29. Skoog I., Gustafson D. Hypertension, hypertension-clustering factors and Alzheimer's disease. Neurol. Res. 2003, 25(6):675-680.
30. Solfrizzi V., Panza F., et al. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004, 63(10):1882-1891.
31. Sundstrom J., Sullivan L., et al. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005, 45(1):28-33.
32. Tohgi H., Abe T., et al. The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson's disease. J. Neural Transm. Park. Dis. Dement. Sect. 1993, 6(2):119-126.
33. Tombaugh T.N., McIntyre N.J. The mini-mental state examination: a comprehensive review. J. Am. Geriatr. Soc. 1992, 40(9):922-935.
34. Vannorsdall T.D., Jinnah H.A., et al. Cerebral ischemia mediates the effect of serum uric acid on cognitive function. Stroke 2008, 39(12):3418-3420.
35. Waugh W.H. Inhibition of iron-catalyzed oxidations by attainable uric acid and ascorbic acid levels: therapeutic implications for Alzheimer's disease and late cognitive impairment. Gerontology 2008, 54(4):238-243.
36. Weir C.J., Muir S.W., et al. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003, 34(8):1951-1956.
37. Yaffe K., Kanaya A., et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004, 292(18):2237-2242.
38. Zhu X., Raina A.K., et al. Alzheimer's disease: the two-hit hypothesis. Lancet Neurol. 2004, 3(4):219-226.